Back to search
Nonarteritic Anterior Ischemic Optic Neuropathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Nonarteritic Anterior Ischemic Optic Neuropathy trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Nonarteritic Anterior Ischemic Optic Neuropathy trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
Ischemic optic neuropathy (ION) is damage to the optic nerve caused by ischemia and hypoxia of the optic nerve due to an impairment of the blood supply to the o…
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially…
This prospective randomized clinical study aims to evaluate the efficacy and safety of autologous platelet-rich plasma (PRP) injection in patients with acute no…